| Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced … SE Al-Batran, N Homann, C Pauligk, TO Goetze, J Meiler, S Kasper, ... The Lancet 393 (10184), 1948-1957, 2019 | 1934 | 2019 |
| Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small … H West, M McCleod, M Hussein, A Morabito, A Rittmeyer, HJ Conter, ... The Lancet Oncology 20 (7), 924-937, 2019 | 1347 | 2019 |
| Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes DK Jin, K Shido, HG Kopp, I Petit, SV Shmelkov, LM Young, AT Hooper, ... Nature medicine 12 (5), 557-567, 2006 | 789 | 2006 |
| Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients … SE Al-Batran, RD Hofheinz, C Pauligk, HG Kopp, GM Haag, KB Luley, ... The lancet oncology 17 (12), 1697-1708, 2016 | 711 | 2016 |
| The bone marrow vascular niche: home of HSC differentiation and mobilization HG Kopp, ST Avecilla, AT Hooper, S Rafii Physiology 20 (5), 349-356, 2005 | 693 | 2005 |
| Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells AT Hooper, JM Butler, DJ Nolan, A Kranz, K Iida, M Kobayashi, HG Kopp, ... Cell stem cell 4 (3), 263-274, 2009 | 670 | 2009 |
| Tyrosine kinase inhibitors-a review on pharmacology, metabolism and side effects JT Hartmann, M Haap, HG Kopp, HP Lipp Current drug metabolism 10 (5), 470-481, 2009 | 663 | 2009 |
| Platelet-derived transforming growth factor-β down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity HG Kopp, T Placke, HR Salih Cancer research 69 (19), 7775-7783, 2009 | 507 | 2009 |
| Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells T Placke, M Örgel, M Schaller, G Jung, HG Rammensee, HG Kopp, ... Cancer research 72 (2), 440-448, 2012 | 408 | 2012 |
| Perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) for … SE Al-Batran, N Homann, H Schmalenberg, HG Kopp, GM Haag, ... Journal of Clinical Oncology 35 (15_suppl), 4004-4004, 2017 | 317 | 2017 |
| Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissue HG Kopp, CA Ramos, S Rafii Current opinion in hematology 13 (3), 175-181, 2006 | 263 | 2006 |
| Integrative genomic and transcriptomic analysis of leiomyosarcoma P Chudasama, SS Mughal, MA Sanders, D Hübschmann, I Chung, ... Nature communications 9 (1), 144, 2018 | 237 | 2018 |
| Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II … W Brugger, J Hirsch, F Grünebach, R Repp, P Brossart, W Vogel, ... Annals of oncology 15 (11), 1691-1698, 2004 | 137 | 2004 |
| Tie2 activation contributes to hemangiogenic regeneration after myelosuppression HG Kopp, ST Avecilla, AT Hooper, SV Shmelkov, CA Ramos, F Zhang, ... Blood 106 (2), 505-513, 2005 | 131 | 2005 |
| Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularization HG Kopp, AT Hooper, MJ Broekman, ST Avecilla, I Petit, M Luo, T Milde, ... The Journal of clinical investigation 116 (12), 3277-3291, 2006 | 123 | 2006 |
| Steady-state neutrophil homeostasis is dependent on TLR4/TRIF signaling S Bugl, S Wirths, MP Radsak, H Schild, P Stein, MC André, MR Müller, ... Blood, The Journal of the American Society of Hematology 121 (5), 723-733, 2013 | 120 | 2013 |
| Outcomes with pembrolizumab plus platinum-based chemotherapy for patients with NSCLC and stable brain metastases: pooled analysis of KEYNOTE-021,-189, and-407 SF Powell, D Rodríguez-Abreu, CJ Langer, A Tafreshi, L Paz-Ares, ... Journal of Thoracic Oncology 16 (11), 1883-1892, 2021 | 101 | 2021 |
| GITR ligand provided by thrombopoietic cells inhibits NK cell antitumor activity T Placke, HR Salih, HG Kopp The Journal of Immunology 189 (1), 154-160, 2012 | 101 | 2012 |
| A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat T Milde, S Kleber, A Korshunov, H Witt, T Hielscher, P Koch, HG Kopp, ... Acta neuropathologica 122, 637-650, 2011 | 97 | 2011 |
| ß-Galactosidase staining on bone marrow. The osteoclast pitfall HG Kopp, AT Hooper, SV Shmelkov, S Rafii Histology and histopathology, 2007 | 95 | 2007 |
